Advanced

The Media Centre includes all the latest news from Terrence Higgins Trust, as well as useful resources for journalists and broadcasters. 

6 June, 2007

Statement in response to the recall of Viracept

Roger Pebody from Terrence Higgins Trust said: It’s essential that anyone taking Nelfinavir (Viracept) contacts their HIV doctor or hospital without delay, to identify an alternative treatment to continue with. 

Nelfinavir (Viracept) is a drug that has been used in the UK since 1998, and many of the anti-HIV drugs which have been developed since then are more effective.  For that reason, the numbers of people using this drug are probably relatively small.  However the contamination and recall of the drug is of great concern to those people who are currently taking the drug, and we would urge anyone doing so to seek their doctor’s advice immediately.

We don’t have many details about the contamination, and how quickly Roche have reacted to it.  We hope that Roche are putting all the necessary effort into creating an uncontaminated supply of the drug as fast as possible.

Ends

For further information, please contact:

Lucy Handford, Press Officer
Telephone: +44 (0)20 7812 1623
Email: lucy.handford@tht.org.uk

Sally Wright, Head of Media
Telephone: +44 (0)20 7812 1625
Email: sally.wright@tht.org.uk